In the media 8 Jul 2026 No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials The Print
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Scientific articles 9 Jul 2026 Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring PLOS Neglected Tropical Diseases
In the media 9 Jul 2026 Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy The Indian Express
Press Releases Translations 8 Jul 2026 Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia
Press Releases Translations 8 Jul 2026 Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India
Press releases 23 Sep 2025 Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
Press releases 15 Sep 2025 Switzerland renews commitment to DNDi to advance medical innovation for neglected patients
Press releases 22 Aug 2025 DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa
Press releases 23 Jul 2025 AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease
Press releases 10 Jul 2025 New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease
Press releases 1 Jul 2025 Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment
Press releases 13 Jun 2025 K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases
Press releases 13 Jun 2025 Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries
Press releases 5 Jun 2025 Colombia becomes first country to recommend rapid tests to diagnose Chagas disease
Press releases 22 May 2025 Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis
Press releases 13 May 2025 First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Press releases 15 Apr 2025 New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease
Press releases 18 Mar 2025 DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team